Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
LITHANE | SEARCHLIGHT PHARMA INC | Anticipated shortage | 150MG | Updated Report | 2024-05-13 | 227896 |
OCUFLOX | ABBVIE CORPORATION | Actual shortage | 0.3% | Updated Report | 2024-05-13 | 217532 |
METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Actual shortage | 25MG | Updated Report | 2024-05-13 | 224951 |
ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 40MG | Updated Report | 2024-05-13 | 215056 |
ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 40MG | Updated Report | 2024-05-13 | 209765 |
ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 20MG | Updated Report | 2024-05-13 | 194733 |
ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 10MG | Updated Report | 2024-05-13 | 217358 |
ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 10MG | Updated Report | 2024-05-13 | 214534 |
ACH-ROSUVASTATIN | ACCORD HEALTHCARE INC | Actual shortage | 5MG | Updated Report | 2024-05-13 | 218314 |
ACH-ESCITALOPRAM | ACCORD HEALTHCARE INC | Actual shortage | 20MG | Updated Report | 2024-05-13 | 224568 |
ACH-AMLODIPINE | ACCORD HEALTHCARE INC | Actual shortage | 2.5MG | Updated Report | 2024-05-13 | 214531 |
VENLAFAXINE XR | SANIS HEALTH INC | Actual shortage | 37.5MG | Updated Report | 2024-05-13 | 225878 |
VARDENAFIL | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-13 | 222747 |
RISPERIDONE | SANIS HEALTH INC | Actual shortage | 0.25MG | Updated Report | 2024-05-13 | 223270 |
FOQUEST | ELVIUM LIFE SCIENCES | Actual shortage | 100MG | Updated Report | 2024-05-13 | 151791 |
COSOPT PRESERVATIVE-FREE | ELVIUM LIFE SCIENCES | Anticipated shortage | 5MG 20MG | New Report | 2024-05-13 | 227864 |
JAMP TELMISARTAN-HCT | JAMP PHARMA CORPORATION | Actual shortage | 12.5MG 80MG | Updated Report | 2024-05-13 | 211816 |
JAMP TAMSULOSIN | JAMP PHARMA CORPORATION | Actual shortage | 0.4MG | Updated Report | 2024-05-13 | 218723 |
JAMP AMOXI CLAV | JAMP PHARMA CORPORATION | Actual shortage | 125MG 875MG | Updated Report | 2024-05-13 | 223977 |
SANDOZ ALFUZOSIN | SANDOZ CANADA INCORPORATED | Actual shortage | 10MG | Updated Report | 2024-05-13 | 225209 |
TIMOLOL MALEATE-EX | SANDOZ CANADA INCORPORATED | Anticipated shortage | 0.25% | New Report | 2024-05-13 | 227853 |
SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 20MG | Updated Report | 2024-05-13 | 224166 |
SANDOZ LEFLUNOMIDE | SANDOZ CANADA INCORPORATED | Anticipated shortage | 10MG | New Report | 2024-05-13 | 227847 |
SANDOZ BRIMONIDINE | SANDOZ CANADA INCORPORATED | Anticipated shortage | 0.2% | New Report | 2024-05-13 | 227844 |
SANDOZ AMLODIPINE | SANDOZ CANADA INCORPORATED | Anticipated shortage | 5MG | New Report | 2024-05-13 | 227841 |
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | Actual shortage | 1000UNIT | Updated Report | 2024-05-13 | 182837 |
SANDOZ DICLOFENAC RAPIDE | SANDOZ CANADA INCORPORATED | Actual shortage | 50MG | Updated Report | 2024-05-13 | 222606 |
!!T3 SANDOZ-CARBAMAZEPINE CR | SANDOZ CANADA INCORPORATED | Actual shortage | 200MG | Updated Report | 2024-05-13 | 221829 |
SANDOZ ROSUVASTATIN | SANDOZ CANADA INCORPORATED | Actual shortage | 5MG | Updated Report | 2024-05-13 | 226673 |
SANDOZ DAPAGLIFLOZIN | SANDOZ CANADA INCORPORATED | Actual shortage | 10MG | Updated Report | 2024-05-13 | 221380 |
CLINDAMYCIN IV INFUSION | SANDOZ CANADA INCORPORATED | Actual shortage | 18MG | Updated Report | 2024-05-13 | 225956 |
FUROSEMIDE SPECIAL | SANDOZ CANADA INCORPORATED | Resolved | 250MG | Updated Report | 2024-05-13 | 125156 |
!!T3 SANDOZ-CARBAMAZEPINE CR | SANDOZ CANADA INCORPORATED | Actual shortage | 400MG | Updated Report | 2024-05-13 | 225212 |
!!T3 TEGRETOL CR | NOVARTIS PHARMACEUTICALS CANADA INC | Actual shortage | 200MG | Updated Report | 2024-05-13 | 227205 |
!!T3 TEGRETOL CR | NOVARTIS PHARMACEUTICALS CANADA INC | Actual shortage | 400MG | Updated Report | 2024-05-13 | 227209 |
SABRIL | LUNDBECK PHARMACEUTICALS LLC | Resolved | 500MG | Updated Report | 2024-05-13 | 164487 |
SABRIL | LUNDBECK PHARMACEUTICALS LLC | Resolved | 500MG | Updated Report | 2024-05-13 | 189885 |
SURVANTA | ABBVIE CORPORATION | Resolved | 25MG | Updated Report | 2024-05-11 | 226027 |
VISIPAQUE 270 | GE HEALTHCARE CANADA INC | Actual shortage | 550MG | Updated Report | 2024-05-11 | 227151 |
MIDAZOLAM INJECTION | SANDOZ CANADA INCORPORATED | Resolved | 5MG | Updated Report | 2024-05-11 | 192022 |
AVENTYL | AA PHARMA INC | Resolved | 10MG | Updated Report | 2024-05-11 | 224511 |
BREVICON 0.5/35 TABLETS (28-DAY PACK) | PFIZER CANADA ULC | Actual shortage | .5MG .035MG | Updated Report | 2024-05-11 | 226997 |
ARTHROTEC 75 | PFIZER CANADA ULC | Actual shortage | 200MCG 75MG | Updated Report | 2024-05-11 | 227000 |
ACH-OLMESARTAN HCTZ | ACCORD HEALTHCARE INC | Actual shortage | 40MG 25MG | Updated Report | 2024-05-11 | 227794 |
APO-FINGOLIMOD | APOTEX INC | Actual shortage | 0.5MG | Updated Report | 2024-05-10 | 216744 |
APO-TICAGRELOR | APOTEX INC | Actual shortage | 90MG | Updated Report | 2024-05-10 | 225026 |
APO-WARFARIN | APOTEX INC | Actual shortage | 1MG | Updated Report | 2024-05-10 | 225782 |
APO-WARFARIN | APOTEX INC | Actual shortage | 1MG | Updated Report | 2024-05-10 | 224589 |
APO-ATORVASTATIN | APOTEX INC | Actual shortage | 80MG | Updated Report | 2024-05-10 | 227088 |
METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Resolved | 20MG | Updated Report | 2024-05-10 | 225687 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN PHARMACEUTICALS ULC | Discontinued | 0.4MG | New Report | 2024-05-08 | 227338 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG 0.5MG | New Report | 2024-05-03 | 227052 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG | New Report | 2024-05-03 | 227049 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 0.5MG | New Report | 2024-05-03 | 227046 |
AUBAGIO | SANOFI-AVENTIS CANADA INC | To be discontinued | 14MG | New Report | 2024-05-02 | 226847 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226748 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226753 |
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-05-02 | 224344 |
SANDOZ D 10 000 | SANDOZ CANADA INCORPORATED | Discontinued | 10000UNIT | Updated Report | 2024-05-02 | 226738 |
SANDOZ DOCUSATE SODIUM | SANDOZ CANADA INCORPORATED | Discontinued | 100MG | Updated Report | 2024-05-02 | 226758 |